| Prev Close | 201.57 |
| Day Low/High | 198.89 / 203.56 |
| 52 Wk Low/High | 150.37 / 228.91 |
| Avg Volume | 1.60M |
Constellation Brands Inc. (STZ)
201.17
NYSE : Consumer Non-Durables
| Exchange | NYSE |
| Shares Outstanding | 167.24M |
| Market Cap | 38.58B |
| EPS | 18.20 |
| P/E Ratio | 16.13 |
| Div & Yield | 3.00 (1.47%) |
Latest News
Would You Rather Have an Executive Team Managing the Company or the Stock Price?
It all comes down to matching my time frame.
Constellation Brands: I Like the Beer a Lot More Than I Like the Stock
I'm only considering selling the puts. The dividend is not that attractive.
Constellation Brands Could Trade Sideways - Watch the OBV Line for Bullish Clues
Let's see if we can identify the next sustained move.
Constellation Brands Remains Beer Dependent as it Transforms Itself
Changes will come as they move their wine and spirits business to the 'high end', and develop the activities of Canopy Growth, which promises cannabis-infused drinks.
June Rotations and Why I Like Apple on Jony Ive's Departure: Market Recon
The risk is that the chief design officer's departure will cause technical issues in Apple's chart.
Constellation Brands Looking Wobbly as Beer Demand Fizzles
Get defensive on the beverage company.
3 Big Earnings Reports to Watch This Week
Some key names are set to release their latest earnings results.
At Canopy Growth it's a Question of Expansion vs. Value
Canopy Growth's latest financial results offer a reality check.
Should Investors Buy the Dip in Canopy Growth Stock?
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
Burn Out
I just wrote a piece for Real Money covering fourth-quarter earnings for Canopy Growth , the name most analysts refer to as the top cannabis play in Canada. As you have likely seen by now, the company's operational loss for the quarter printed ugly...
Canopy Growth's Latest Results Can Be Wrapped Up in One Word: Ugly
The cannabis company's performance as outlined in its year-end report should not inspire investor confidence.
Canopy Growth Slips as Production, Margins Disappoint
While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.
Best and Worst Beer Stocks
Wetting my whistle with these 2 beer names, plus 2 stocks to avoid.
Trouble Brewing at Constellation Brands
For me, this one is a pass. For now.
Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
I Own Alphria Stock and the Big Q3 Loss Was Not a Surprise
The company has spent a lot of time and money trying to meet the supply needs of the recreational cannabis market.
2 Huge Earnings Reports I'm Watching This Week
A pair of earnings report this week will shed light on the future direction of two fast-growing companies in very different fields.
Here's How to Trade Constellation Brands Stock
Oh, by the way, Constellation, for those who've forgotten, holds a 38% stake in Canopy Growth.
Constellation Brands Stock Can Still Run Despite Downgrade
There is certainly too much to ignore about STZ for the majority of analysts.
Jim Cramer: Betting That the Next Pieces of News Will Be Very Stock Heartening
The consumer is alive, well, and might benefit from a thaw with China and easy to get jobs. So would Boeing and Caterpillar.
Constellation Brands Focuses on Beer, Tesla Deliveries Underwhelm
What I do know is that TSLA now faces a tumultuous uphill battle in order to meet its full year guidance.
Investing in 5G, the Next Industrial Revolution; What I Think About Apple Stock
I am upping my Apple price target.
2 Important Earnings Reports I'm Watching This Week
What to look for when Dave & Buster's and Constellation Brands report results.
About Those CBD-Infused Beverages
I've noted a few names from the comments that may be involved in the CBD-infused beverage market in the form of New Age Beverage Corp. and Constellation Brands . While I'm a big supporter in the potential of CBD and cannabis, I have my reservations ...
Cannabis Enters Its Most Challenging Stage for Investors and Traders
Not to be outcome by a unicorn company, the unicorn sector of the markets, cannabis, is unleashing a blitzkrieg of news this morning. On the acquisition side, Cresco Labs is buying Origin House (CannaRoyalty) this morning for a small premium. It app...
7 Indirect Stock Plays on the Cannabis Sector
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
Tilray Stock Lights Up as Partnerships Obscure Profitability Problem
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.
